Central Garden & Pet Company (CENT)

For Centene, managing pharmacy benefits while maintaining competitive premium structures requires careful actuarial work and risk management. The company’s ability to navigate these dynamics will prove critical to achieving its stated goal of break-even performance in Medicare Advantage. The combina…

However, these themes coexist with short-term sensitivities to weather, retailer inventory actions, and promotional intensity, which can add volatility around earnings updates. ... Additional news and developments on the stock can be explored via the linked overview pages. ... Central Garden ...

Centrus Energy currently trades at $216.75, up from $206.04 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Central Garden & Pet Company's both Pet and Garden segments posted revenue and profit growth. Read why I upgraded CENT stock from a hold to a soft buy.

Investing.com - Deutsche Bank upgraded Centene (NYSE:CNC) to Buy from Hold on Tuesday and raised its price target to $80 from $53. The new price target reflects 12 times the firm’s 2028 earnings per share estimate of $6.70 for the health insurer. The stock currently trades at $59.15, up nearly ...